Myriad Genetics - 25 Year Stock Price History | MYGN

Historical daily share price chart and data for Myriad Genetics since 1995 adjusted for splits. The latest closing stock price for Myriad Genetics as of July 31, 2020 is 12.07.
  • The all-time high Myriad Genetics stock closing price was 64.25 on November 06, 2000.
  • The Myriad Genetics 52-week high stock price is 47.10, which is 290.2% above the current share price.
  • The Myriad Genetics 52-week low stock price is 9.24, which is 23.4% below the current share price.
  • The average Myriad Genetics stock price for the last 52 weeks is 21.38.
Myriad Genetics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 16.7547 27.3500 29.5300 9.7800 12.0700 -55.67%
2019 28.8167 29.0000 47.0800 20.9300 27.2300 -6.33%
2018 37.0251 34.9100 50.3400 27.2300 29.0700 -15.36%
2017 25.3318 16.9300 37.1400 15.4000 34.3450 106.03%
2016 28.9086 42.8300 42.8300 16.2600 16.6700 -61.38%
2015 36.9074 34.6100 46.1600 30.9400 43.1600 26.72%
2014 35.2888 21.7200 42.2100 21.0300 34.0600 62.35%
2013 27.1721 27.6800 34.2600 20.7900 20.9800 -23.01%
2012 25.3547 21.0000 30.6500 20.3600 27.2500 30.13%
2011 20.8191 22.2300 25.5300 17.8600 20.9400 -8.32%
2010 19.8918 26.6600 26.9200 14.4900 22.8400 -12.46%
2009 32.2280 34.1900 46.0000 22.8500 26.0900 -21.25%
2008 26.3477 23.0700 35.5150 17.3900 33.1300 42.74%
2007 20.5935 15.6750 29.4150 15.6150 23.2100 48.31%
2006 12.8096 10.8100 15.7750 10.5400 15.6500 50.48%
2005 9.6963 11.0600 12.9400 7.6000 10.4000 -7.60%
2004 8.3728 6.7900 11.9550 6.0950 11.2550 75.04%
2003 6.4309 7.5050 8.9600 4.3000 6.4300 -11.92%
2002 12.3661 25.1950 25.1950 6.6750 7.3000 -72.26%
2001 25.5927 34.7500 38.6250 12.9650 26.3200 -36.39%
2000 32.8078 11.4375 64.2500 10.3750 41.3750 259.78%
1999 3.6261 2.6575 11.7500 2.1563 11.5000 360.00%
1998 3.9467 6.0625 6.3125 1.8750 2.5000 -58.76%
1997 7.0036 6.0625 11.3450 5.4375 6.0625 -3.96%
1996 6.4582 7.3750 8.8125 4.3125 6.3125 -22.62%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.900B $0.851B
Myriad Genetics, Inc. is focused on revolutionizing patient care through the discovery, development and marketing of transformative molecular diagnostic tests that address pressing clinical needs across multiple medical specialties. Myriad is the pioneer and leader in molecular diagnostics, offering innovative products that transform patients' lives. These products include leading molecular diagnostic tests for hereditary cancer, urological cancer, lung cancer, autoimmune disorders and other diseases. Myriad has invested heavily in educating patients and healthcare professionals about the role genes and proteins play in disease. Myriad's hereditary cancer genetic testing, which helps healthcare professionals better manage and tailor medical care. Myriad is expanding their reach and increasing their impact on patient care by introducing new molecular diagnostic and companion diagnostic tests for a growing number of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.302B 15.56
Bristol Myers Squibb (BMY) United States $132.729B 11.09
Gilead Sciences (GILD) United States $87.217B 12.55
CSL (CSLLY) Australia $86.987B 0.00
Vertex Pharmaceuticals (VRTX) United States $70.523B 39.53
Regeneron Pharmaceuticals (REGN) United States $69.539B 26.81
Illumina (ILMN) United States $56.178B 57.73
Biogen (BIIB) United States $43.487B 7.44
Seattle Genetics (SGEN) United States $28.782B 0.00
Moderna (MRNA) United States $27.508B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.913B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.463B 9.36
Genmab (GMAB) Denmark $22.342B 18.38
BioMarin Pharmaceutical (BMRN) United States $21.666B 196.41
Incyte (INCY) United States $21.468B 0.00
Genmab (GNMSF) Denmark $20.660B 61.34
BeiGene (BGNE) Cayman Islands $18.676B 0.00
BioNTech SE (BNTX) Germany $18.578B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.814B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.496B 70.16
Exact Sciences (EXAS) United States $14.205B 0.00
Galapagos (GLPG) Belgium $12.015B 35.34
Sarepta Therapeutics (SRPT) United States $11.973B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.674B 28.73
QIAGEN (QGEN) Netherlands $11.262B 32.75
ARGENX SE-ADR (ARGX) Netherlands $10.818B 0.00
Bio-Techne Corp (TECH) United States $10.517B 69.49
Immunomedics (IMMU) United States $9.751B 0.00
Novavax (NVAX) United States $8.294B 0.00
Guardant Health (GH) United States $8.056B 0.00
Repligen (RGEN) United States $7.923B 125.76
Ascendis Pharma (ASND) Denmark $7.272B 0.00
Exelixis (EXEL) United States $7.081B 24.83
ACADIA Pharmaceuticals (ACAD) United States $6.479B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.369B 15.84
CRISPR Therapeutics AG (CRSP) Switzerland $5.997B 185.78
Emergent Biosolutions (EBS) United States $5.832B 23.32
Vir Biotechnology (VIR) United States $5.631B 0.00
Acceleron Pharma (XLRN) United States $5.338B 0.00
Mirati Therapeutics (MRTX) United States $5.294B 0.00
Reata Pharmaceuticals (RETA) United States $4.909B 0.00
Adaptive Biotechnologies (ADPT) United States $4.786B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.662B 0.00
Zai Lab (ZLAB) China $4.422B 0.00
MorphoSys AG (MOR) Germany $4.231B 32.82
MyoKardia (MYOK) United States $4.207B 0.00
China Biologic Products (CBPO) China $4.186B 23.27
Global Blood Therapeutics (GBT) United States $4.112B 0.00
NeoGenomics (NEO) United States $4.027B 1274.33
Blueprint Medicines (BPMC) United States $3.966B 0.00
Amicus Therapeutics (FOLD) United States $3.723B 0.00
Halozyme Therapeutics (HALO) United States $3.693B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.471B 0.00
Bluebird Bio (BLUE) United States $3.378B 0.00
Arena Pharmaceuticals (ARNA) United States $3.090B 0.00
Inovio Pharmaceuticals (INO) United States $3.073B 0.00
Alkermes (ALKS) Ireland $2.864B 60.03
Principia Biopharma (PRNB) United States $2.762B 0.00
Insmed (INSM) United States $2.639B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.590B 0.00
Amarin (AMRN) Ireland $2.498B 0.00
Denali Therapeutics (DNLI) United States $2.474B 0.00
Fate Therapeutics (FATE) United States $2.429B 0.00
Twist Bioscience (TWST) United States $2.296B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.881B 73.24
Sorrento Therapeutics (SRNE) United States $1.870B 0.00
Viela Bio (VIE) United States $1.867B 0.00
UniQure (QURE) Netherlands $1.855B 0.00
I-Mab (IMAB) China $1.823B 0.00
Editas Medicine (EDIT) United States $1.622B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.589B 0.00
Mesoblast (MESO) Australia $1.568B 0.00
Eidos Therapeutics (EIDX) United States $1.545B 0.00
Sangamo Therapeutics (SGMO) United States $1.526B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.504B 0.00
Epizyme (EPZM) United States $1.399B 0.00
Zymeworks (ZYME) Canada $1.390B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.364B 0.00
Adverum Biotechnologies (ADVM) United States $1.347B 0.00
Revance Therapeutics (RVNC) United States $1.340B 0.00
Mersana Therapeutics (MRSN) United States $1.331B 0.00
Intra-Cellular Therapies (ITCI) United States $1.317B 0.00
Zealand Pharma (ZEAL) Denmark $1.289B 0.00
Cytokineticsorporated (CYTK) United States $1.286B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.247B 8.71
NGM Biopharmaceuticals (NGM) United States $1.246B 0.00
Alector (ALEC) United States $1.238B 0.00
Arvinas (ARVN) United States $1.233B 0.00
REGENXBIO (RGNX) United States $1.233B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.217B 0.00
NantKwest (NK) United States $1.101B 0.00
Akcea Therapeutics (AKCA) United States $1.096B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.086B 0.00
Alcobra (ARCT) United States $1.076B 0.00
Beam Therapeutics (BEAM) United States $0.996B 0.00
Compugen (CGEN) Israel $0.986B 0.00
VBI Vaccines (VBIV) United States $0.939B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Intellia Therapeutics (NTLA) United States $0.915B 0.00
Arcus Biosciences (RCUS) United States $0.906B 0.00
Heska (HSKA) United States $0.904B 0.00
Athenex (ATNX) United States $0.866B 0.00
Retrophin (RTRX) United States $0.858B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.825B 0.00
Cara Therapeutics (CARA) United States $0.769B 0.00
Dynavax Technologies (DVAX) United States $0.748B 0.00
Vericel (VCEL) United States $0.744B 137.42
Intrexon (PGEN) United States $0.725B 0.00
Pharming Group (PHGUF) Netherlands $0.707B 16.14
Codexis (CDXS) United States $0.698B 0.00
Morphic Holding (MORF) United States $0.690B 0.00
Castle Biosciences (CSTL) United States $0.667B 0.00
Cellectis S.A (CLLS) France $0.667B 0.00
Frequency Therapeutics (FREQ) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
ZIOPHARM Oncology Inc (ZIOP) United States $0.636B 0.00
MiMedx (MDXG) United States $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.594B 0.00
Kadmon Holdings (KDMN) United States $0.586B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.550B 4.71
Cue Biopharma (CUE) United States $0.538B 0.00
Agenus (AGEN) United States $0.521B 0.00
Anika Therapeutics (ANIK) United States $0.517B 22.61
Syndax Pharmaceuticals (SNDX) United States $0.509B 0.00
Athersys (ATHX) United States $0.503B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.500B 0.00
AnaptysBio (ANAB) United States $0.490B 0.00
Prothena (PRTA) Ireland $0.489B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Kala Pharmaceuticals (KALA) United States $0.478B 0.00
UROGEN PHARMA (URGN) United States $0.462B 0.00
DBV Technologies S.A (DBVT) France $0.452B 0.00
Clovis Oncology (CLVS) United States $0.445B 0.00
AC Immune SA (ACIU) Switzerland $0.441B 0.00
Syros Pharmaceuticals (SYRS) United States $0.434B 0.00
Protagonist Therapeutics (PTGX) United States $0.432B 0.00
Albireo Pharma (ALBO) United States $0.423B 0.00
BioDelivery Sciences (BDSI) United States $0.420B 22.05
Avid Bioservices (CDMO) United States $0.419B 0.00
Puma Biotechnology (PBYI) United States $0.406B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Kamada (KMDA) Israel $0.394B 16.41
Prometic Life Sciences (LMNL) Canada $0.385B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.382B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.372B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 7.10
PDL BioPharma (PDLI) United States $0.362B 318.00
Scholar Rock Holding (SRRK) United States $0.337B 0.00
MannKind (MNKD) United States $0.332B 0.00
Precision BioSciences (DTIL) United States $0.330B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.327B 0.00
Geron (GERN) United States $0.323B 0.00
CytomX Therapeutics (CTMX) United States $0.322B 0.00
WAVE Life Sciences (WVE) Singapore $0.314B 0.00
ChromaDex (CDXC) United States $0.311B 0.00
ADMA Biologics Inc (ADMA) United States $0.308B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.306B 0.00
Seres Therapeutics (MCRB) United States $0.285B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.280B 0.00
Starpharma Holdings (SPHRY) Australia $0.279B 0.00
OSMOTICA PHARM (OSMT) United States $0.276B 0.00
Menlo Therapeutics (MNLO) United States $0.270B 0.00
Affimed (AFMD) Germany $0.269B 0.00
Arbutus Biopharma (ABUS) United States $0.263B 0.00
Northwest Biotherapeutics (NWBO) United States $0.257B 0.00
Cellular Biomedicine (CBMG) United States $0.255B 0.00
Pluristem Therapeutics (PSTI) Israel $0.250B 0.00
Trevena (TRVN) United States $0.249B 0.00
NextCure (NXTC) United States $0.245B 0.00
Spero Therapeutics (SPRO) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
Dyadic (DYAI) United States $0.238B 0.00
Celldex Therapeutics (CLDX) United States $0.232B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.231B 0.00
Fortress Biotech (FBIO) United States $0.229B 0.00
Aduro Biotech (ADRO) United States $0.228B 0.00
Verastem (VSTM) United States $0.218B 0.00
Five Prime Therapeutics (FPRX) United States $0.216B 0.00
HOOKIPA Pharma (HOOK) United States $0.211B 0.00
Selecta Biosciences (SELB) United States $0.208B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.208B 9.70
IVERIC Bio (ISEE) United States $0.206B 0.00
Exicure (XCUR) United States $0.195B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.188B 0.00
Theratechnologies (THTX) Canada $0.186B 0.00
GENFIT S.A (GNFT) France $0.186B 0.00
XOMA (XOMA) United States $0.184B 0.00
Strongbridge Biopharma (SBBP) United States $0.183B 0.00
Sutro Biopharma (STRO) United States $0.180B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aptinyx (APTX) United States $0.172B 0.00
Aytu Bioscience (AYTU) United States $0.168B 0.00
Cerecor (CERC) United States $0.163B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Bellus Health (BLU) Canada $0.158B 0.00
Liquidia Technologies (LQDA) United States $0.157B 0.00
Cidara Therapeutics (CDTX) United States $0.150B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Eton Pharmaceuticals (ETON) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.135B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.134B 0.00
TELA Bio (TELA) United States $0.133B 0.00
Kindred Biosciences (KIN) United States $0.129B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Oncobiologics (OTLK) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
Orgenesis (ORGS) United States $0.121B 0.00
Gritstone Oncology (GRTS) United States $0.119B 0.00
Lumos Pharma (LUMO) United States $0.117B 0.00
PHASEBIO PHARMA (PHAS) United States $0.115B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.115B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
Cyclerion Therapeutics (CYCN) United States $0.106B 0.00
Vaccinex (VCNX) United States $0.105B 0.00
AIT Therapeutics (XAIR) United States $0.105B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.103B 0.00
AquaBounty Technologies (AQB) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.096B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Emmaus Life Sciences (EMMA) United States $0.093B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.089B 0.00
Cocrystal Pharma (COCP) United States $0.088B 0.00
Antibe Therapeutics (ATBPF) Canada $0.086B 0.00
Organovo Holdings (ONVO) United States $0.086B 0.00
DiaMedica Therapeutics (DMAC) United States $0.084B 0.00
Unum Therapeutics (UMRX) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.077B 0.00
Proteostasis Therapeutics (PTI) United States $0.077B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
AnPac Bio-Medical Science (ANPC) China $0.071B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
Idera Pharmaceuticals (IDRA) United States $0.067B 0.00
Bionano Genomics (BNGO) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Soligenix (SNGX) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Happiness Biotech Group (HAPP) China $0.062B 0.00
Catalyst Biosciences (CBIO) United States $0.062B 0.00
Edesa Biotech (EDSA) Canada $0.061B 0.00
Signal Genetics (MGEN) United States $0.059B 0.00
IMMURON (IMRN) Australia $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
Apricus Biosciences (SEEL) United States $0.052B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.048B 0.00
Curis (CRIS) United States $0.043B 0.00
Spherix (AIKI) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Genetic Technologies (GENE) Australia $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Pulmatrix (PULM) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Acorda Therapeutics (ACOR) United States $0.030B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.017B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00